TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
WGS

GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

97.80$ -3.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow WGS
Line item 2019 2020 2021 2022 2023 2024 2025
+83.1% +85.8% +172.0% -39.6% -38.7% +14.9%
+2,093.2% +82.5% -80.9% -100.8% +252.0%
+2,211.2% -79.6% +435.5%
-41.7% +347.3% -205.8%
+106.9% -35.0% -31.1% -60.1% -3.9% +246.3%
+106.9% -35.0% +579.9% -69.1% -31.1% +104.2%
-214.8% -75.6% -107.5% +13.6%
-12.8% +282.6% -60.0% -5.6% -76.3% +8.7%
-96.5% +7,044.9% -193.2%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?